baber/WOPTO huggingface dataset:
Patent PT-728450-E (PT)
Inventor: SCOTT RICHARD D
IPC: A61F2/38
Filed: 1996-02-26
Abstract: An improved knee prosthesis disclosed that includes a patella for positioning in a trochlear groove formed by two condyles of a femoral component. The novel patella of the disclosure has an elliptical outer periphery and presents an articulating surface to the femoral component for sliding engagement with a trochlear groove formed between the condyles of the femoral component. A side opposite the articulating surface has extending therefrom three posts which enhance the attachment of the patella prosthesis to the patella bone. In one embodiment of the invention an undercut area which is cut into the bone contacting surface of the prosthesis presents an overhang or undercut to the bone in order to enhance cement fixation. The overhang is formed by an outer defining wall which is positioned at an angle to a bottom surface of the recessed overhang area of between 50 and 75 DEG .
Patent PT-745412-E (PT)
Inventor: BERNER MARK K
IPC: A63F13/12
Filed: 1996-05-30
Abstract: Apparatus for a game of skill played simultaneously by several players (for example, a live television quiz game) whereby each participant player effectively competes only against players having a similar skill level in order to provide a strong motivation. The system includes a central computer system (11) with each remote participant or groups of participants having a control unit (12). The control unit (12) either stores and has supplied to it the particular skill level of the player and at the end of the game, only the relative scores at that particular skill level are indicated to that player. The system also provides for effective promotion or updating to a higher skill level of successful players of the game and/or game event. <IMAGE>
Patent PT-830348-E (PT)
Inventor: YUEN PO-WAI
IPC: C07D491/113
Filed: 1996-05-13
Abstract: A novel series of substituted quinoxaline 2,3-diones of Formula I    <IMAGE>  I  useful as neuroprotective agents are taught. Novel intermediates, processes of preparation, and pharmaceutical compositions containing the compounds are also taught. The compounds are glutamate antagonists and are useful in the treatment of stroke, cerebral ischemia, or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, status epilepticus, perinatal asphyxia, anoxia, seizure disorders, pain, Alzheimer's, Parkinson's, and Huntington's Diseases.
Patent PT-990000-E (PT)
Inventor: EBNER REINHARD
IPC: A01N37/18
Filed: 1996-11-08
Abstract: The present invention relates to a novel connective tissue growth factor-3 protein which is a member of the growth factor superfamily. In particular, isolated nucleic acid molecules are provided encoding the human connective tissue growth factor-3 protein. Connective tissue growth factor-3 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic and therapeutic methods for detecting and treating connective tissue related disorders.
Patent PT-882154-E (PT)
Inventor: ABRIBAT BENOIT
IPC: D21H21/24
Filed: 1997-02-10
Abstract: The invention concerns in particular a composition for a softening lotion used in fiber treatment. In the invention, the lotion composition is aqueous and liquid at a temperature of at least 5° C. and comprises, as active substances: (a) one or more saturated linear fatty alcohols having at least 16 carbon atoms, and (b) one or more waxy esters having a total of at least 24 carbon atoms. The application of the invention is to the manufacture of fibrous products such as disposable absorbent paper products.
Patent PT-887074-E (PT)
Inventor: NABAHI SHOHRE
IPC: A61K9/00
Filed: 1998-06-23
Abstract: The invention provides an intravaginal drug delivery system having a first intravaginal part comprising at least one active agent in a polymer matrix, said first part being provided in association with a second part comprising a removable polymer membrane arranged to absorb excess active agent. Use of a polymer membrane in this way serves to substantially reduce the initial high burst of active from the intravaginal part following administration. It also reduces the levels of release of active during the first few weeks of use. Also provided is an intravaginal drug delivery device comprising at least one active agent dispersed in a polymer matrix, wherein the concentration of active agent at the outer surface of the device at the time of use is not substantially higher than the concentration of the active agent in the remainder of the device.
Patent PT-994112-E (PT)
Inventor: HARTMANN HORST
IPC: C07D307/33
Filed: 1999-09-02
Abstract: Separation of impurities from 3-(2'-acetoxyethyl)-dihydro-2(3H)-furanone (I) obtained by acetylation of 3-(2'-hydroxyethyl)-dihydro-2(3H)-furanone comprises first separating high boiling impurities and subjecting the recovered distillation head product to a further step in which light and medium boiling components are taken off at the head and recovering pure (I) as the sump product.
Patent PT-1068184-E (PT)
Inventor: MEWSHAW RICHARD ERIC
IPC: A61K31/403
Filed: 1999-04-07
Abstract: Compounds effective in treating disorders of the serotonin-affected neurological systems are provided, such compounds having (I), wherein: R1 and R2 are each, independently, hydrogen, halogen, CF3, lower alkyl, lower alkoxy, MeSO2, or together can form a 5-7 membered carbocyclic or heterocyclic ring; R3 is alkoxy, halogen, hydrogen or carbamoyl; R4 is hydrogen, hydroxy, lower alkyl, or lower alkoxy; R5 is hydrogen, lower alkyl, or halogen; R6 is hydrogen, lower alkyl, or phenyl; R7 is hydrogen, loyer alkyl, lower alkoxy, halogen, CN, CF3, or hydroxy; and X is (CH2)n, wherein n is 0 to 3; or pharmaceutically acceptable salts thereof.
Patent PT-1192599-E (PT)
Inventor: GLIZE JEAN-PIERRE
IPC: G07B11/00
Filed: 1999-06-30
Abstract: The invention concerns a device feeding tickets in continuous strip for a ticket processing device, comprising at least a first tray (BA1) arranged substantially horizontally and containing a first continuous strip of tickets (BN1), each defined by perforated lines, and fan folded in said first tray (BA1), and a first output (S1) designed to feed the ticket processing device (DIS). The feeding device comprises at least a first return and guide member (OR1), for defining a first substantially vertical path (CV1) starting from the first tray (BA1) up to the first member (OR1) and a first substantially horizontal path (CH1) starting from the first member (OR1) up to the first output (S1), the first vertical and horizontal paths forming between them a substantially right angle at one first site (E1), and the first strip (BN1) is folded in the proximity of the first site (E1) along the perforated lines of two adjacent tickets, when said first strip (BN1) is at rest.
Patent PT-1107929-E (PT)
Inventor: ALLEN PETER GEORGE
IPC: B66D1/74
Filed: 1999-08-25
Abstract: Rope-holding characteristics of a winch drum (2) are determined by a staggered array of pyramidal protuberances (12, 14, 17, 19) on its surface. The staggering is such that there is no true circular path round the drum within the array, and a rope wound on it in the hoop direction is deflected sinusoidally.
Patent PT-1090203-E (PT)
Inventor: KRAEUTLER BERNARD
IPC: E06B9/174
Filed: 1999-06-22
Abstract: In a goods-handling door, there is a bracket on either side of its top portion. The brackets serve to support the shaft for rolling up the door. The invention relates to a one-piece (molded) bracket offering various functions: guiding the curtain, fixing various accessories, thereby ensuring structural precision and easy maintenance.
Patent SG-38287-G (SG)
Title: Mixed anhydride steroid intermediate and process for preparing steroid intermediates
IPC: C07C51/56
Filed: 1987-05-22
Abstract: (A process for preparing steroid intermediates of the formula 
<CHEM>
 in which pivaloyl chloride is added to a compound of the formula 
<CHEM>
 the resulting compound of the formula 
<CHEM>
 is reacted with a Grignard reagent of the formula 
<CHEM>
 wherein X is Cl or Br,
 and the resulting compound of the formula 
<CHEM>
 is cyclized in the presence of a base. 
<??>Compound I in turn may be readily converted by known methods to valuable steroids. 
<??>Disclosed as a mixed anhydride steroid intermediate of formula III is 7a beta -methyl-2,3,3a alpha , 4, 5, 6, 7; 7a-octahydro-1H-inden-1,5-dione-4 alpha -(3-propionic acid) pivalic acid mixed anhydride.)
Patent SG-179394-G (SG)
Title: Scaling circuitry with truncation offset compensation
Inventor: FLING RUSSELL THOMAS
IPC: H03H17/04
Filed: 1994-12-22
Abstract: A scaling circuit for scaling PCM signals by factors less than one includes a bit-shift and truncating circuit (61). Roundoff error compensating circuitry adds (60) an offset value - (38)to the samples (15) to be scaled by the bit-shift circuitry to compensate for errors produced by truncation without rounding. The offset values may be dithered to increase the apparent resolution of the system.
Patent IE-810051-L (IE)
Title: Plastisol compositions
IPC: C08K5/10
Filed: 1981-01-12
Abstract: A plastisol composition comprising a mixture of a butyl phthalate and an alkyl benzene in a volume ratio between 90:10 and 40:60 is used, for example, to make conventional plastisol coating formulations. The butyl phthalate is preferably di-isobutyl phthalate and the alkyl benzene can be, for example, dodecyl benzene.
Patent IE-810107-L (IE)
Title: 17-aminosteroids
IPC: C07J41/00
Filed: 1981-01-21
Abstract: New and pharmacologically useful 17-amino-16-hydroxy-steroids of the androstane and oestrane series are disclosed having the formula I: <CHEM> and pharmaceutically acceptable non-toxic acid addition salts thereof, wherein: R1 = H or hydrocarbyl of one to six carbon atoms (preferably lower alkyl, such as methyl); R2 = H or hydrocarbyl of one to six carbon atoms (preferably lower alkyl, such as methyl);  R3 = a free, esterified or etherified hydroxyl group; ring A inclusive carbon atoms 6 and 9 has one of the following configurations: <CHEM>  in which  R4 = a free, esterified or etherified hydroxyl group; R5 = O or H(R7), wherein R7 is a free, esterified or etherified hydroxyl group;  R6 = H or methyl; and the dotted lines represent an optional double bond in 4,5- or 5,6-position;  as well as the enantiomers and racemates of these steroids. The novel compounds have antiarrhythmic properties.
Patent IE-44594-L (IE)
Title: Accelerating the drying of offset printing ink
IPC: C09D11/02
Filed: 1977-02-01
Abstract: A method is disclosed for accelerating the drying of offset inks. An additive composition comprising (a) 15 to 85 percent of functional amino polydimethylsiloxane and (b) 85 to 15 percent of a mixture of ethylene oxide and propylene oxide, wherein the ethylene oxide is present in an amount of from 15 to 85 percent with respect to the propylene oxide, is added to an offset printing ink.
[US4110118A]
Patent IE-820211-L (IE)
Title: Process for preparing 2-penem compounds
IPC: C07D487/04
Filed: 1982-01-29
Abstract: Compounds of the general formula: <CHEM> in which R1, R2, R3, X and 2 are as defined herein, and their pharmaceutically acceptable salts;  especially those subject to the following provisos:  (i) when X is S, Z is O or =NR7 (R7 being as defined herein);  (ii) when X is O, Z is O, S or =NR7;  (iii) when X is -CH2-, Z is =NR7; (except that when R7 is H or C1-C6 alkyl and R2 is C1-C6 alkyl, then R1 cannot be acylamino;  (iv) when X is (CH2)2, Z is=NR7; and their pharmaceutically acceptable salts. These compounds are antibacterial agents which can be incorporated into pharmaceutical compositions or used as intermediates in the preparation of such agents.
Patent IE-33123-L (IE)
Title: Vaccines
IPC: C07K16/12
Filed: 1969-05-27
Abstract: 1,248,097. Vaccines. INSTITUT MERIEUX. 27 May, 1969 [28 May, 1968], No. 26822/69. Heading A5B. Vaccines comprise a combination of an agglutinogenic antigen with sufficient of an immune serum to that antigen to saturate all the agglutinogenic sites of the antigen. Vaccines specified are effective against brucellosis, coli-bacillosis, salmonellosis, staphylococial illness, streptococcal illness, tuberculosis, whooping cough, cholera, plague, Newcastle disease and influenza. The antigen may consist of inactivated whole bacteria or attenuated live bacteria.
[GB1248097A]
Patent FI-820440-L (FI)
Inventor: BAUER ROBERT
IPC: C12Q1/54
Filed: 1982-02-10
Abstract: Test system for the determination of glucose in aqueous fluids of the type which comprises glucose oxidase, a peroxidatively active substance and chromogen. Use of m-anisidine as a chromogen which permits the semi-quantitative determination of glucose at higher concentrations than is possible with previously used chromogens.
Patent FI-822384-L (FI)
Inventor: AMMON HELMUT KARL
IPC: A01M1/16
Filed: 1982-07-05
Abstract: An improved fly paper comprising a strip coated with sticky material and which, for increasing the possible size of the strip, is made of foil or paper reinforced by high tensile threads. The strip is folded about a line located generally halfway between its ends and rolled up, while folded double; the roll being covered by the two ends of the strip which are uncoated. The strip ends are provided with eyes for hanging up the strip on use.
Patent FI-852711-L (FI)
Inventor: HOFMANN GUNTER A
IPC: A23L3/26
Filed: 1985-07-09
Abstract: The invention concerns a method for sterilizing food products by killing or deactivating microorgansims without altering the taste or other properties of the food product. The food product in a container with high electrical resistivity is placed inside an electromagnetic coil 10 and subjected to one or more pulses from an oscillating magnetic field which has an intensity of about 2-100 tesla and a frequency of about 5- 500 kHz. The magnetic field in the coil 10 is generated by discharging a capacitor 14. The capacitor is charged from a source 16 and, when a switch 18 is closed for completing the circuit which includes the capacitor and coil, an oscillating current is generated between the plates in the capacitor 14, which current in turn generates an oscillating magnetic field, which is concentrated in the region 20 delimited by the coil 10. The method can also be used for sterilizing material and container. <IMAGE>
Patent FI-853908-L (FI)
Inventor: LESUER WILLIAM MONROE
IPC: C07D307/60
Filed: 1985-10-08
Abstract: An improvement in known processes for preparing substituted carboxylic acids useful as acylating agents which comprise reacting (A) at least one aliphatic polymer of one or more lower olefins with (B) an acid reactant selected from the group consisting of fumaric acid, itaconic acid, maleic acid, and the corresponding anhydrides, lower alkyl esters, acyl chlorides and acyl bromides, in the presence of chlorine can be improved by the steps of (i) reacting at a temperature of about 100<o>-200<o>C, a mixture of (A) and (B) in the presence of about 0.05 to 0.15 equivalent of chlorine per equivalent of (A) until of the chlorine has reacted to provide a first intermediate product, (ii) continuing the reaction in the absence of chlorine at a temperature of from about 180<o>-250<o>C until a conversion of 0.4 to 1.1 equivalents of (B) per equivalent of (A) is attained to provide a second intermediate product, and (iii) reacting said second intermediate with about 0.2 to 1.5 equivalents of chlorine per equivalent of (A) used in step (i) at a temperature of about 180<o>-225<o>C. The carboxylic acids produced by this improved process can be used, per se, in lubricants and fuels and as acylating agents in reactions with amines, alcohols, reactive metals or reactive metal compounds to form derivative products which are useful, for example, as additives for lubricants and normally liquid fuels.
Patent IE-45524-L (IE)
Title: Complement inhibitors
IPC: A61K31/70
Filed: 1977-07-12
Abstract: Sulfated oligosaccharides of the maltose series useful as complement inhibitors.
[US4021544A]
Patent IE-36824-L (IE)
Title: Carbon fibres
IPC: D01F9/145
Filed: 1972-11-03
Abstract: A process for the production of carbon fibers from coal-tar pitch or from other strongly aromatic distillation residues wherein an oxygen-containing polymer is added to the starting material before or during the heat treatment which is followed by the usual stages of spinning, oxidizing and carbonizing.
[US3966887A]
Patent IE-801577-L (IE)
Title: Copolymers of propylene and but-1-ene
IPC: B32B27/32
Filed: 1980-07-29
Abstract: The invention concerns a process for the production of copolymers of propylene and but-1-ene which can be used for the production of hollow bodies or heat-sealable films and wherein the proportion by weight of units derived from but-1-ene is from 10 to 40% and wherein the proportion of isolated ethyl branches is at least equal to the square of the proportion of units derived from propylene contained in said polymers. The process is characterized in that a gaseous mixture of propylene and but-1-ene is brought into contact, in the absence of liquid diluent, with a catalytic system which is stereospecific in the polymerization of propylene alone.
[US4360650A]
Patent IE-43582-L (IE)
Title: Desoxystreptamine derivatives
IPC: A61P31/04
Filed: 1976-07-23
Abstract: 1502537 2 - Desoxy - streptamine derivatives ROUSSEL-UCLAF 23 July 1976 [23 July 1975] 30746/76 Heading C2C Novel N 1 - [L(-) - 2 - hydroxy - 4 - aminobutyryl] - 4 - O - [2<SP>1</SP>,6<SP>1</SP> - diamino - 2<SP>1</SP>,6<SP>1</SP> - didesoxy - α,D - glucopyranosyl] - 6 - O - [3<SP>11</SP>- methylamino - 3<SP>11</SP>,4<SP>11</SP>,6<SP>11</SP> - tridesoxy - α,D- xylohexopyranosyl] - 2 - desoxystreptamine (I) and addition salts thereof with mineral or organic acids are prepared by reacting 4-O- [2<SP>1</SP>,6<SP>1</SP> - diamino - 21,61 - didesoxy - α,D - glucopyranosyl] - 6 - O - [3<SP>11</SP> - methylamino - 3<SP>11</SP>,4<SP>11</SP>, 6<SP>11</SP> - tridesoxy - α,D - xylohexopyranosyl] - 2- desoxystreptamine with N - benzyloxycarbonyloxy-succinimide, reacting the resulting novel 4 - O - [21 - amino - 61 - benzyloxycarbonylamino - 2<SP>1</SP>,6<SP>1</SP> - didesoxy - α,D - glucopyranosyl] - 6 - O - [3<SP>11</SP> - methylamino - 3<SP>11</SP>,4<SP>11</SP>, 6<SP>11</SP> - tridesoxy - α,D - xylohexopyranosyl] - 2- desoxystreptamine with the N-hydroxysuccinimide ester of L-(-)-γ-benzyloxycarbonylamino - α - hydroxy - butyric acid and catalytically hydrogenating the resulting novel N 1 - [L - (-) - 2 - hydroxy - 4 - benzyloxycarbonylamino - butyryl] - 4 - O - [2<SP>1</SP> - amino- 61 - benzyloxycarbonylamino - 2<SP>1</SP>,6<SP>1</SP> - didesoxy- α,D - glucopyranosyl] - 6 - O - [3<SP>11</SP> - methylamino - 3<SP>11</SP>,4<SP>11</SP>,6<SP>11</SP> - tridesoxy - α,D - xylohexopyranosyl] - 2 - desoxystreptamine, followed optionally by salification with an appropriate acid. Pharmaceutical compositions having antibiotic activity comprise, as active ingredient, the compound (I) or a pharmaceutically acceptable mineral or organic acid addition salt thereof, in association with a suitable pharmaceutical vehicle.
[GB1502537A]
Patent IE-901684-L (IE)
Title: Pusher blade for an analyzer
IPC: G01N35/04
Filed: 1990-05-09
Abstract: There are three different types of test elements which can be used in analyzers, namely CM (colorimetric) types, rate types and PM (potentiometric) types. Each type of element normally requires its own incubation and reading station. This has resulted in analyzers which have three incubators and read stations. This adds considerably to the cost of the analyzer, and the space which it occupies. Disclosed herein is an analyzer arrangement (20) which includes an incubator (500) and two circular paths (22, 24) are arranged around the incubator (500). Cartridges (C) are loaded with test elements (E, E') at a cartridge-loading station 300), the station (300) being disposed above the paths (22, 24) and positioned to one side of the incubator (500). A transfer device (400) is positioned at another location around the periphery of the incubator (500) and loads test elements from any cartridge (C) located on the circular paths (22, 24) into the incubator (500). An electrometer (360) is also positioned around the periphery of the incubator (500) for reading the incubated test elements. CM type and rate type test elements are read within the incubator (500).
[EP0397256A2]
Patent IE-882142-L (IE)
Title: Naphthothiazepine derivatives and preparation thereof
IPC: C07D281/12
Filed: 1988-07-13
Abstract: A novel naphthpthiazepine derivative of the formula: <CHEM> wherein R<1> is a lower alkoxy group, R<2> is hydrogen atom or a lower alkanoyl group, and R<3> and R<4> are the same or different and hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable acid addition salt thereof, are disclosed. Said derivative (I) and a salt thereof are useful as hypotensive agents and/or coronary or cerebral vasodilators.
Patent IE-872453-L (IE)
Title: A new system for administration of liposomes to mammals
IPC: A61K47/00
Filed: 1987-09-11
Abstract: A new system to administer liposomal formulations to mammals, including man, comprising a dry lipid-based solid material, which in an aqueous milieu spontaneously form or reconstitute liposomes, and a device for aerosolizing a selected quantity of the lipid-based solid material in a suitable form, is described. The invention is particularily suitable for applications where the lipid-based solid composition is inhaled as a finely-divided powder in aerosol form and hydrated in the respiratory tract.
[EP0260241A1]
Patent IE-852943-L (IE)
Title: Vinylchloride polymer resin compositions
IPC: C08L51/00
Filed: 1985-11-22
Abstract: Disclosed is a vinyl chloride polymer composition comprising: (i) 100 parts by weight of a vinyl chloride polymer containing at least 80 wt. % of vinyl chloride units, and (ii) 0.05 to 25 wt. parts of a three-stage polymer (II), which is obtained by polymerizing 10 to 30 wt. parts of at least one monomer (B), which is selected from acrylic acid esters, methacrylic acid esters, aromatic vinyl compounds, cyano-vinyl compounds and vinyl ester compounds so that the glass transition temperature of a polymer obtained by separately polymerizing the monomer (B) is 0 DEG to 60 DEG C., in the presence of 45 to 85 wt. parts of a methyl methacrylate polymer (A) containing at least 80 wt. % of methyl methacrylate units; and then polymerizing 5 to 25 wt. parts of a methyl methacrylate monomer or monomer mixture (C) containing at least 80 wt. % of methyl methacrylate in the presence of the obtained copolymer comprising the components (A) and (B) so that the total amount of the components (A), (B), and (C) is 100 wt. parts. The vinyl chloride polymer composition is advantageous in that the gelation speed is high, the parting property at the calendering step is good, adhesion to the vessel wall is not caused at the blending step before the processing, the processability is excellent, and the composition gives a molded articles having a good transparency and a good surface condition.
[US4699948A]
Patent IE-883159-L (IE)
Title: Wave powered prime mover
IPC: F03B13/16
Filed: 1988-10-19
Abstract: The prime-mover comprises a central inertial barge 1, a first outer wave-engaging pontoon 2 pivotally movable relative to the central barge 1 about the pivotal axis defined by the arrow A, and a second outer wave-engaging pontoon 3 pivotally movable relative to the central barge 1 about the axis defined by the arrow B. Two series of pumps 4 are mounted on the central barge 1 and driven by the pivotal movement of the outer wave-engaging pontoons 2,3 respectively. A damping mechanism comprising two shafts 6a,6b extend downwardly from the bage 1. The shafts 6a,6b are provided with damping plates 7a,7b at the bottom ends thereof. The damping plates 7a,7b may be moved relative to the shafts 6a,6b by being screwed up or down the shafts as required.